Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Olmesartan franchise

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Olmesartan franchise was produced by Daiichi Sankyo.

Novartis builds its case for novel MS treatment ofatumumab

Novartis builds its case for novel MS treatment ofatumumab

The drug is an important product in Novartis’ growing MS franchise, which currently includes Mayzent (siponimod), a next-generation treatment approved for use in active secondary progressive multiple sclerosis (SPMS).

Gilead’s top-line slips 10% as demand for HIV/hepatitis C drugs drops

Gilead’s top-line slips 10% as demand for HIV/hepatitis C drugs drops Gilead is pinning the blame on the disruption caused by the ongoing COVID-19 pandemic, as demand for its core hepatitis C and HIV franchises declined.

AstraZeneca escapes pandemic impact as new drugs bolster revenues

AstraZeneca escapes pandemic impact as new drugs bolster revenues Strong sales and continued demand for AZ’s cardiovascular, renal and metabolism (CVRM) and oncology franchises helped to push sales in the quarter despite disruption caused by the pandemic. ... Over in its CVRM franchise, total revenue reached $2.26bn

AZ strengthens Daiichi Sankyo partnership with new ADC deal

AZ strengthens Daiichi Sankyo partnership with new ADC deal Both cancer types are of particular interest for AZ as it plans to extend its oncology franchise beyond its approved therapies, which include PD-1 inhibitor Imfinzi (durvalumab), lymphoma treatment

Roche cites COVID-19 and biosimilars in Q2 decline

Roche cites COVID-19 and biosimilars in Q2 decline completely offset the decline to its established franchises and steady the impact from COVID-19.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
11 London

11 London is a strategic and creative agency working in the fields of health and humanity – complex areas, but...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics